Women are predisposed to early dose-limiting toxicities during adjuvant CAPOX for colorectal cancer

CONCLUSION: Women were prone to early DLTs during adjuvant CAPOX in the current study. Doctors should be aware of the sex difference in the incidence of early DLTs, and adjust the CAPOX dosage and provide supportive care for female CRC patients.PMID:34516723 | DOI:10.1111/ijcp.14863

Source: Clinical Colorectal Cancer - September 13, 2021 Category: Cancer & Oncology Authors: Hiroaki Nozawa Kazushige Kawai Kazuhito Sasaki Koji Murono Shigenobu Emoto Yuichiro Yokoyama Shinya Abe Junko Kishikawa Yuzo Nagai Hirofumi Sonoda Hiroyuki Anzai Tsuyoshi Ozawa Soichiro Ishihara Source Type: research